Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LN016 sustained-release gel for postoperative analgesia after abdominal surgery
ChiCTR2600133483Phase 2Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Sep 2026
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in postoperative pain (6 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Area under the pain intensity-time curve at rest from 0 to 72 hours and Area under the pain rating score-time curve at rest from 0 to 72 hours. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600133483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133483.